Real-world data for predictors of PSA response to Lu177-PSMA-617 in metastatic castration resistant prostate cancer

被引：0
|
作者：
Hassoun, Rebecca [1 ]
Tann, Mark [1 ]
Sims, Justin [1 ]
Auxier, Ashleigh [1 ]
Althouse, Sandra K. [1 ]
King, Jennifer [1 ]
Adra, Nabil [1 ]
机构：
[1] Indiana Univ, Simon Comprehens Canc Ctr, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Predictors of PSA response to Lu177-PSMA-617 in metastatic castration-resistant prostate cancer
    Tann, Mark
    Sims, Justin
    Auxier, Ashleigh
    Althouse, Sandra K.
    Salous, Tareq
    King, Jennifer
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 135 - 135
  • [2] Xerostomia and ocular dryness as predictors of PSA response to Lu177-PSMA-617 in metastatic castration resistant prostate cancer
    Hassoun, Rebecca
    Tann, Mark
    Sims, Justin
    Auxier, Ashleigh
    Althouse, Sandra K.
    Salous, Tareq
    King, Jennifer
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Imaging and clinical factors impacting PSA response in patients with metastatic castrate resistant prostate cancer undergoing Lu177-PSMA-617 therapy
    Boughdad, Sarah
    Meyer, Marie
    Da Mota, Michael
    Allenbach, Gilles
    Nicod-Lalonde, Marie
    Prior, John
    Schaefer, Niklaus
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [4] Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"
    Radtke, Jan Philipp
    Albers, Peter
    Giesel, Frederik Lars
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [5] Transformation of PSMA-avid to FDG-avid disease in metastatic castration-resistant prostate cancer in the setting of biochemical response with LU177-PSMA-617
    Sidhu, A.
    Singh, P.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2025, 17
  • [6] Real world outcomes of 177Lu-PSMA-617 PSMA in a racially diverse cohort of patients with metastatic castration resistant prostate cancer (mCRPC).
    Gerke, Margo
    Marra, Angelo
    Liu, Yuan
    Muzahir, Saima
    Brown, Jacqueline T.
    Nazha, Bassel
    Berchuck, Jacob E.
    Parikh, Ravi Bharat
    Ciuro, Jordan Alana
    Hartman, Caitlin
    Mcclintock, Greta Russler
    Caulfield, Sarah
    Kucuk, Omer
    Carthon, Bradley Curtis
    Schuster, David M.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [7] Safety and response to177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Zang, Jie
    Liu, Qingxing
    Jacobson, Orit
    Niu, Gang
    Fan, Xinrong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [8] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [9] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [10] [177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study
    Satapathy, Swayamjeet
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Sahoo, Ranjit Kumar
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (08) : 2495 - 2503
12345